Oncotarget

Research Papers:

PI3K/AKT/mTOR pathway plays a major pathogenetic role in glycogen accumulation and tumor development in renal distal tubules of rats and men

Silvia Ribback _, Antonio Cigliano, Nils Kroeger, Maria G. Pilo, Luigi Terracciano, Martin Burchardt, Peter Bannasch, Diego F. Calvisi and Frank Dombrowski

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:13036-13048. https://doi.org/10.18632/oncotarget.3675

Metrics: PDF 1734 views  |   HTML 1601 views  |   ?  


Abstract

Silvia Ribback1, Antonio Cigliano1, Nils Kroeger2, Maria G. Pilo1, Luigi Terracciano3, Martin Burchardt2, Peter Bannasch4, Diego F. Calvisi1, Frank Dombrowski1

1Institut für Pathologie, Universitätsmedizin Greifswald, Germany

2Klinik für Urologie, Universitätsmedizin Greifswald, Germany

3Molekularpathologie, Institut für Pathologie, Universitätsspital Basel, Switzerland

4German Cancer Research Center, Heidelberg, Germany

Correspondence to:

Silvia Ribback, e-mail: silvia.ribback@uni-greifswald.de

Keywords: AKT/mTOR, nephrocarcinogenesis, glycogen, clear cell tubules

Received: February 04, 2015     Accepted: April 06, 2015     Published: April 16, 2015

ABSTRACT

Activation of the PI3K/AKT/mTOR pathway is a crucial molecular event in human clear cell renal cell carcinoma (ccRCC), and is also upregulated in diabetic nephropathy. In diabetic rats metabolic changes affect the renal distal tubular epithelium and lead to glycogen-storing Armanni-Ebstein lesions (AEL), precursor lesions of RCC in the diabetes induced nephrocarcinogenesis model. These lesions resemble human sporadic clear cell tubules (CCT) and tumor cells of human ccRCC.

Human sporadic CCT were examined in a collection of 324 nephrectomy specimen, in terms of morphologic, metabolic and molecular alterations, and compared to preneoplastic CCT and RCC developed in the rat following streptozotocin-induced diabetes or N-Nitrosomorpholine administration. Diabetic and non-diabetic rats were subjected to the dual PI3K/mTOR inhibitor, NVP/BEZ235.

Human sporadic CCT could be detected in 17.3% of kidney specimens. Human and rat renal CCT display a strong induction of the PI3K/AKT/mTOR pathway and related metabolic alterations. Proteins involved in glycolysis and de novo lipogenesis were upregulated. In in vivo experiments, dual inhibition of PI3K and mTOR resulted in a reduction of proliferation of rat diabetes related CCT and increased autophagic activity.

The present data indicate that human sporadic CCT exhibit a pattern of morphologic and metabolic alterations similar to preneoplastic lesions in the rat model. Activation of the PI3K/AKT/mTOR pathway in glycogenotic tubuli is a remarkable molecular event and suggests a preneoplastic character of these lesions also in humans.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 3675